163 related articles for article (PubMed ID: 28664355)
1. Using Multiple Pharmacovigilance Models Improves the Timeliness of Signal Detection in Simulated Prospective Surveillance.
van Gaalen RD; Abrahamowicz M; Buckeridge DL
Drug Saf; 2017 Nov; 40(11):1119-1129. PubMed ID: 28664355
[TBL] [Abstract][Full Text] [Related]
2. The impact of exposure model misspecification on signal detection in prospective pharmacovigilance.
van Gaalen RD; Abrahamowicz M; Buckeridge DL
Pharmacoepidemiol Drug Saf; 2015 May; 24(5):456-67. PubMed ID: 25187155
[TBL] [Abstract][Full Text] [Related]
3. The effect of exposure misclassification in spontaneous ADR reports on the time to detection of product-specific risks for biologicals: a simulation study.
Vermeer NS; Ebbers HC; Straus SM; Leufkens HG; Egberts TC; De Bruin ML
Pharmacoepidemiol Drug Saf; 2016 Mar; 25(3):297-306. PubMed ID: 26676881
[TBL] [Abstract][Full Text] [Related]
4. Structured assessment for prospective identification of safety signals in electronic medical records: evaluation in the health improvement network.
Cederholm S; Hill G; Asiimwe A; Bate A; Bhayat F; Persson Brobert G; Bergvall T; Ansell D; Star K; Norén GN
Drug Saf; 2015 Jan; 38(1):87-100. PubMed ID: 25539877
[TBL] [Abstract][Full Text] [Related]
5. Towards Automating Adverse Event Review: A Prediction Model for Case Report Utility.
Muñoz MA; Dal Pan GJ; Wei YJ; Delcher C; Xiao H; Kortepeter CM; Winterstein AG
Drug Saf; 2020 Apr; 43(4):329-338. PubMed ID: 31912439
[TBL] [Abstract][Full Text] [Related]
6. Estimating time-to-onset of adverse drug reactions from spontaneous reporting databases.
Leroy F; Dauxois JY; Théophile H; Haramburu F; Tubert-Bitter P
BMC Med Res Methodol; 2014 Feb; 14():17. PubMed ID: 24490673
[TBL] [Abstract][Full Text] [Related]
7. A Pilot, Predictive Surveillance Model in Pharmacovigilance Using Machine Learning Approaches.
De Abreu Ferreira R; Zhong S; Moureaud C; Le MT; Rothstein A; Li X; Wang L; Patwardhan M
Adv Ther; 2024 Jun; 41(6):2435-2445. PubMed ID: 38704799
[TBL] [Abstract][Full Text] [Related]
8. A signal detection method to detect adverse drug reactions using a parametric time-to-event model in simulated cohort data.
Cornelius VR; Sauzet O; Evans SJ
Drug Saf; 2012 Jul; 35(7):599-610. PubMed ID: 22702641
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
10. vigiRank for statistical signal detection in pharmacovigilance: First results from prospective real-world use.
Caster O; Sandberg L; Bergvall T; Watson S; Norén GN
Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):1006-1010. PubMed ID: 28653790
[TBL] [Abstract][Full Text] [Related]
11. A conceptual approach to the masking effect of measures of disproportionality.
Maignen F; Hauben M; Hung E; Holle LV; Dogne JM
Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):208-17. PubMed ID: 24243699
[TBL] [Abstract][Full Text] [Related]
12. Statistical Signal Detection as a Routine Pharmacovigilance Practice: Effects of Periodicity and Resignalling Criteria on Quality and Workload.
Lerch M; Nowicki P; Manlik K; Wirsching G
Drug Saf; 2015 Dec; 38(12):1219-31. PubMed ID: 26391801
[TBL] [Abstract][Full Text] [Related]
13. Time Series Disturbance Detection for Hypothesis-Free Signal Detection in Longitudinal Observational Databases.
Whalen E; Hauben M; Bate A
Drug Saf; 2018 Jun; 41(6):565-577. PubMed ID: 29468602
[TBL] [Abstract][Full Text] [Related]
14. The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project.
Raschi E; Poluzzi E; Salvo F; Koci A; Suling M; Antoniazzi S; Perina L; Hazell L; Moretti U; Sturkenboom M; Garbe E; Pariente A; De Ponti F
Drug Saf; 2016 Jan; 39(1):59-68. PubMed ID: 26446144
[TBL] [Abstract][Full Text] [Related]
15. Useful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal Detection.
Pacurariu AC; Straus SM; Trifirò G; Schuemie MJ; Gini R; Herings R; Mazzaglia G; Picelli G; Scotti L; Pedersen L; Arlett P; van der Lei J; Sturkenboom MC; Coloma PM
Drug Saf; 2015 Dec; 38(12):1201-10. PubMed ID: 26370104
[TBL] [Abstract][Full Text] [Related]
16. A meta-epidemiological study found lack of transparency and poor reporting of disproportionality analyses for signal detection in pharmacovigilance databases.
Khouri C; Revol B; Lepelley M; Mouffak A; Bernardeau C; Salvo F; Pariente A; Roustit M; Cracowski JL
J Clin Epidemiol; 2021 Nov; 139():191-198. PubMed ID: 34329725
[TBL] [Abstract][Full Text] [Related]
17. Minimizing signal detection time in postmarket sequential analysis: balancing positive predictive value and sensitivity.
Maro JC; Brown JS; Dal Pan GJ; Kulldorff M
Pharmacoepidemiol Drug Saf; 2014 Aug; 23(8):839-48. PubMed ID: 24700557
[TBL] [Abstract][Full Text] [Related]
18. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
Tandon VR; Mahajan V; Khajuria V; Gillani Z
Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
[TBL] [Abstract][Full Text] [Related]
19. Using real-world healthcare data for pharmacovigilance signal detection - the experience of the EU-ADR project.
Patadia VK; Coloma P; Schuemie MJ; Herings R; Gini R; Mazzaglia G; Picelli G; Fornari C; Pedersen L; van der Lei J; Sturkenboom M; Trifirò G;
Expert Rev Clin Pharmacol; 2015 Jan; 8(1):95-102. PubMed ID: 25487079
[TBL] [Abstract][Full Text] [Related]
20. Sequence symmetry analysis in pharmacovigilance and pharmacoepidemiologic studies.
Lai EC; Pratt N; Hsieh CY; Lin SJ; Pottegård A; Roughead EE; Kao Yang YH; Hallas J
Eur J Epidemiol; 2017 Jul; 32(7):567-582. PubMed ID: 28698923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
